CIDE-3 interacts with lipopolysaccharide-induced tumor necrosis factor, and overexpression increases apoptosis in

Jie Min1, Wei Zhang, Yu Gu

  • 1State Key Laboratory Of Cancer Biology, Department of pathology, Xijing Hospital, The Fourth Military Medical University, 710032 Xi'an, China.

Insights

Cell death-inducing DFF45-like effector-3 (CIDE-3) suppresses hepatocellular carcinoma (HCC) by inducing apoptosis and inhibiting proliferation. This study reveals CIDE-3

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Cell death-inducing DFF45-like effector-3 (CIDE-3) is a novel protein in the apoptosis-inducing family with an unknown function.
  • CIDE-3 exhibits differential expression in hepatocellular carcinoma (HCC) tissues compared to normal adjacent tissues, suggesting a role in HCC pathogenesis.

Purpose of the Study:

  • To investigate the function of CIDE-3 in hepatocellular carcinoma (HCC) and test the hypothesis that it induces apoptosis, thereby inhibiting oncogenesis and tumor development.

Main Methods:

  • Immunohistochemistry was used to assess CIDE-3 expression in 82 HCC and 51 adjacent liver tissue samples.
  • Flow cytometry was employed to detect apoptosis in SMMC-7721 HCC cells with and without CIDE-3 overexpression.
  • A yeast two-hybrid system was utilized to identify CIDE-3 interacting proteins.

Main Results:

  • CIDE-3 expression was significantly decreased in HCC tissues compared to normal adjacent tissues.
  • CIDE-3 expression positively correlated with HCC differentiation, being lower in poorly differentiated tumors.
  • Overexpression of CIDE-3 in SMMC-7721 cells induced apoptosis and inhibited cell proliferation.
  • The interaction between CIDE-3 and lipopolysaccharide-induced tumor necrosis factor (LITAF) was identified in hepatic cells.

Conclusions:

  • CIDE-3 plays a crucial role in inducing apoptosis and inhibiting proliferation in hepatocellular carcinoma cells.
  • The decreased expression of CIDE-3 in HCC tissues suggests it acts as a tumor suppressor.
  • This study demonstrates the novel interaction between CIDE-3 and LITAF, providing new insights into HCC apoptosis pathways.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.